- Home
- ALGS vs DOMH Comparison
ALGS vs DOMH Comparison
Compare ALGS & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALGS | DOMH |
|---|---|---|
| Founded | 2018 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.6M | 47.2M |
| IPO Year | 2020 | 2010 |
Fundamental Metrics
Financial Performance| Metric | ALGS | DOMH |
|---|---|---|
| Price | $6.37 | $2.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $39.33 | N/A |
| AVG Volume (30 Days) | ★ 188.6K | 115.9K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 22.56% |
| EPS Growth | ★ 88.30 | 34.03 |
| EPS | N/A | ★ N/A |
| Revenue | $2,186,000.00 | ★ $123,104,000.00 |
| Revenue This Year | $32.20 | N/A |
| Revenue Next Year | $4.71 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 578.41 |
| 52 Week Low | $4.20 | $2.69 |
| 52 Week High | $13.69 | $8.40 |
Technical Indicators
Market Signals| Indicator | ALGS | DOMH |
|---|---|---|
| Relative Strength Index (RSI) | 40.80 | 46.98 |
| Support Level | N/A | $2.77 |
| Resistance Level | $8.03 | $3.52 |
| Average True Range (ATR) | 0.72 | 0.18 |
| MACD | -0.20 | 0.01 |
| Stochastic Oscillator | 13.33 | 34.00 |
Price Performance
Historical ComparisonAbout ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.